SCHEMBL29633839

SCHEMBL29633839

CN(C(=O)OCC1c2ccccc2-c2ccccc21)C(CCc1ccc(C(F)(F)F)c(F)c1)C(=O)OC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.33
DAO P14920 1/20 0.32
KCNH2 Q12809 1/20 0.31
TMEM97 Q5BJF2 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
MDM2 Q00987 1/20 0.31
KMT2A Q03164 1/20 0.31
FFAR1 O14842 1/20 0.30
PTPN1 P18031 1/20 0.30
HCRTR1 O43613 1/20 0.30
HCRTR2 O43614 1/20 0.30
TRPM8 Q7Z2W7 1/20 0.30
FABP7 O15540 1/20 0.30
FABP5 Q01469 1/20 0.30
DRD4 P21917 1/20 0.30
GPBAR1 Q8TDU6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29633681 0.91 PPARG (0.33) EPHX2KMT2AFFAR1PTPN1TRPM8
SCHEMBL22454862 0.91 PPARG (0.33) EPHX2KMT2AFFAR1PTPN1TRPM8
SCHEMBL29633950 0.91 PPARG (0.33) EPHX2KMT2AFFAR1PTPN1TRPM8
SCHEMBL29633702 0.91 FABP7 (0.34) EPHX2DAOMDM2KMT2AHCRTR1
SCHEMBL29633877 0.91 EPHX2 (0.34) EPHX2DAOMDM2FFAR1PTPN1
SCHEMBL29633688 0.88 CHRM5 (0.38) KCNH2TMEM97SIGMAR1FABP5
SCHEMBL29633718 0.87 MDM2 (0.34) EPHX2MDM2KMT2AFABP7FABP5
SCHEMBL29634036 0.87 MDM2 (0.38) EPHX2MDM2KMT2AFFAR1PTPN1
SCHEMBL29633952 0.87 KMT2A (0.35) EPHX2MDM2KMT2AFFAR1FABP7
SCHEMBL29633686 0.86 MEN1 (0.41) EPHX2KCNH2MDM2KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR EPHX2 2165/4885DAO 7/4885KCNH2 1976/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR EPHX2 2165/4885DAO 7/4885KCNH2 1976/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR EPHX2 2165/4885DAO 7/4885KCNH2 1976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.